Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics

Context Wuzi Yanzong Prescription (WYP) has long been used to treat male infertility, with convincing clinical evidence. However, its mechanism of action is not clear.Objective WYP chemical components were quantified by HPLC, and the effect on oligoasthenozoospermia rats was explored based on UPLC-Q...

Full description

Bibliographic Details
Main Authors: Zhimin Chen, Baohua Dong, Yunxiu Jiang, Ying Peng, Wenbing Li, Lingying Yu, Yongxiang Gao, Changjiang Hu
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Pharmaceutical Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2022.2101670
_version_ 1811341724694347776
author Zhimin Chen
Baohua Dong
Yunxiu Jiang
Ying Peng
Wenbing Li
Lingying Yu
Yongxiang Gao
Changjiang Hu
author_facet Zhimin Chen
Baohua Dong
Yunxiu Jiang
Ying Peng
Wenbing Li
Lingying Yu
Yongxiang Gao
Changjiang Hu
author_sort Zhimin Chen
collection DOAJ
description Context Wuzi Yanzong Prescription (WYP) has long been used to treat male infertility, with convincing clinical evidence. However, its mechanism of action is not clear.Objective WYP chemical components were quantified by HPLC, and the effect on oligoasthenozoospermia rats was explored based on UPLC-Q-TOF-MS metabonomics technology.Materials and methods The solution was extracted by alcohol and water; the content of eight components in the extracting solution was determined by HPLC. Twenty-four Sprague-Dawley rats were randomly divided into control (CG), model (MG) and administration (PG) groups. Oligoasthenozoospermia was induced for 30 days in all, but the CG with daily oral doses of 20 mg/kg Tripterysium glycosides (TG). PG was given daily oral doses of WYP solution (1.08 g/kg), CG and MG received the same volume of distilled water, all administered for 30 days. After the last administration, the serum samples were collected and detected by UPLC-Q-TOF-MS.Results An HPLC method for simultaneous determination of chlorogenic acid (0.081%), ellagic acid (0.021%), hyperoside (0.032%), verbascoside (0.011%), isoquercitrin (0.041%), astragalin (0.026%), kaempferol (0.009%) and schisandrin (0.014%) was established. Moreover, the 74 potential biomarkers and eight metabolic pathways related to oligoasthenozoospermia were identified by multivariate analysis and metabolite profiling. WYP can regulate 36 markers, mainly involving amino acid metabolism, lipid metabolism and nucleotide metabolism.Discussion and conclusions This is a simple and accurate method for quality control of WYP. It further enriches the potential mechanism of WYP in the treatment of oligoasthenozoospermia. It can provide a theoretical basis for the rational application of WYP.
first_indexed 2024-04-13T18:59:11Z
format Article
id doaj.art-5f4d4aecc9224147a9450c90c0edf6f9
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-13T18:59:11Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-5f4d4aecc9224147a9450c90c0edf6f92022-12-22T02:34:09ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162022-12-016011533154110.1080/13880209.2022.2101670Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomicsZhimin Chen0Baohua Dong1Yunxiu Jiang2Ying Peng3Wenbing Li4Lingying Yu5Yongxiang Gao6Changjiang Hu7State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaInstitute of Qinghai Tibetan Plateau, Southwest Minzu University, Chengdu, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaInternational Education College, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaContext Wuzi Yanzong Prescription (WYP) has long been used to treat male infertility, with convincing clinical evidence. However, its mechanism of action is not clear.Objective WYP chemical components were quantified by HPLC, and the effect on oligoasthenozoospermia rats was explored based on UPLC-Q-TOF-MS metabonomics technology.Materials and methods The solution was extracted by alcohol and water; the content of eight components in the extracting solution was determined by HPLC. Twenty-four Sprague-Dawley rats were randomly divided into control (CG), model (MG) and administration (PG) groups. Oligoasthenozoospermia was induced for 30 days in all, but the CG with daily oral doses of 20 mg/kg Tripterysium glycosides (TG). PG was given daily oral doses of WYP solution (1.08 g/kg), CG and MG received the same volume of distilled water, all administered for 30 days. After the last administration, the serum samples were collected and detected by UPLC-Q-TOF-MS.Results An HPLC method for simultaneous determination of chlorogenic acid (0.081%), ellagic acid (0.021%), hyperoside (0.032%), verbascoside (0.011%), isoquercitrin (0.041%), astragalin (0.026%), kaempferol (0.009%) and schisandrin (0.014%) was established. Moreover, the 74 potential biomarkers and eight metabolic pathways related to oligoasthenozoospermia were identified by multivariate analysis and metabolite profiling. WYP can regulate 36 markers, mainly involving amino acid metabolism, lipid metabolism and nucleotide metabolism.Discussion and conclusions This is a simple and accurate method for quality control of WYP. It further enriches the potential mechanism of WYP in the treatment of oligoasthenozoospermia. It can provide a theoretical basis for the rational application of WYP.https://www.tandfonline.com/doi/10.1080/13880209.2022.2101670Compound contentbiomarkersmetabolic pathwaymechanism
spellingShingle Zhimin Chen
Baohua Dong
Yunxiu Jiang
Ying Peng
Wenbing Li
Lingying Yu
Yongxiang Gao
Changjiang Hu
Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics
Pharmaceutical Biology
Compound content
biomarkers
metabolic pathway
mechanism
title Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics
title_full Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics
title_fullStr Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics
title_full_unstemmed Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics
title_short Effect of Wuzi Yanzong prescription on oligoasthenozoospermia rats based on UPLC-Q-TOF-MS metabolomics
title_sort effect of wuzi yanzong prescription on oligoasthenozoospermia rats based on uplc q tof ms metabolomics
topic Compound content
biomarkers
metabolic pathway
mechanism
url https://www.tandfonline.com/doi/10.1080/13880209.2022.2101670
work_keys_str_mv AT zhiminchen effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT baohuadong effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT yunxiujiang effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT yingpeng effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT wenbingli effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT lingyingyu effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT yongxianggao effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics
AT changjianghu effectofwuziyanzongprescriptiononoligoasthenozoospermiaratsbasedonuplcqtofmsmetabolomics